SPC470
Vadadustat
Status:
UmsóknApplication date:
30.5.2024Application published:
15.6.2024
Max expiry date:
24.4.2038Medicine name:
VafseoMedicine for children:
No
Timeline
Today
30.5.2024Application
15.6.2024Publication
24.4.2038Expires
Marketing license
IS authorization number:
EU/1/23/1725Date:
23.5.2023
Foreign authorization number:
EU/1/23/1725Date:
24.4.2024
Owner
Name:
Akebia Therapeutics, Inc.Address:
245 First Street, Suite 1100, Cambridge, MA 02142 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3007695